Tag: Watchman
Medtech Insights: Trial pipeline underpins growth strategy for Watchman LAAC device
Investment in a programme of clinical trials will underpin Boston Scientific’s strategy to expand th...
TCT 2022: Amulet occluder keeps pace with Watchman at three years
Long-term follow-up of patients with non-valvular atrial fibrillation (AF) receiving the Amplatz...
Boston Scientific announces positive PINNACLE FLX study results
Boston Scientific has announced positive 12-month results from the PINNACLE FLX clinical trial a...
Virtual ACC: Largest left atrial appendage occlusion registry finds Watchman acute safety data “very encouraging”
Data from the National Cardiovascular Data Registry (NCDR) Left Atrial Appendage Occlusion (LAAO...
BIBA Briefings: Longest and largest follow-up data for Watchman supports its role in stroke prevention
Data from the CAP and CAP2 registries—which contain the longest and largest follow-up of patient...
Boston Scientific initiates trial comparing left atrial appendage closure to direct oral anticoagulants for stroke risk reduction post-AFib ablation
According to a press release, Boston Scientific has initiated the OPTION trial to compare safety...
Simultaneous TAVI and left atrial appendage closure is feasible
Thomas S Gilhofer (University Heart Center, Department of Cardiology, University Hospital Zurich...
TCT 2017: Vivek Reddy on the final outcomes of PREVAIL and PROTECT-AF
Boston Scientific has announced the final five-year outcomes data from the PREVAIL study during ...
TCT 2017: Boston Scientific reveals presentations at conference
Boston Scientific has announced key data will be presented at next week’s Transcatheter Cardiova...
Analysis of LAA closure devices reveals post-approval spike in safety events
A retrospective study conducting a safety assessment and comparison between two percut...
TCT 2016: Boston Scientific announces scheduled presentations
Boston Scientific has announced key data that will be presented at the 2016 Transcatheter Cardio...
No significant differences between Watchman and Amplatzer in first comparison
Results from the first study to compare outcomes of two left atrial appendage closure devices—Wa...
Rose Medical Center among first hospitals in Colorado to offer Watchman
Rose Medical Center has become one of the first hospitals in Colorado (USA) to offer patients wi...
CMS recognises LAAO Registry as approved registry to meet national coverage determination requirements
An American College of Cardiology (ACC) press statement reports that the Centers for Medicare an...
